Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Tudor Investment Corp ET AL | 233.6K | $4.0M | 22.97% | -- | 2026-06-30 |
| Ikarian Capital, LLC | 72.3K | $1.0M | 7.10% | -- | 2026-06-30 |
| Millennium Management LLC | 70.8K | $1.0M | 6.96% | -- | 2026-06-30 |
| Balyasny Asset Management L.P. | 70.0K | $12.0M | 6.88% | -- | 2026-06-30 |
| Squadron Capital Management LLC | 40.4K | -- | 3.97% | -- | 2026-06-30 |
| Shay Capital LLC | 17.5K | -- | 1.72% | -- | 2026-06-30 |
| Boothbay Fund Management, LLC | 13.9K | -- | 1.37% | -- | 2026-06-30 |
| Jane Street Group, LLC | 12.6K | -- | 1.24% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 12.0K | -- | 1.18% | -- | 2026-06-30 |
| Cormorant Asset Management, LP | 5.5K | -- | 0.54% | -- | 2026-06-30 |
